Modulation of the cannabinoid receptors by hemopressin peptides

Life Sciences

Volumn 92, Issue 8-9, 2013, Pages 520-524

  Bomar, Martha G ^a   Galande, Amit K ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

Amyloid fibrils; Cannabinoid receptor; Hemopressin; Peptide aggregation; Self assembly

Indexed keywords

1,5 DIARYLPYRAZOLE DERIVATIVE; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; HEMOPRESSIN PEPTIDE; NONAPEPTIDE; RIMONABANT; TETRAHYDROCANNABINOLIC ACID; UNCLASSIFIED DRUG;

ADDICTION; AMINO TERMINAL SEQUENCE; CONFERENCE PAPER; DRUG ACTIVITY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; LIPOPHILICITY; MODULATION; NONHUMAN; OBESITY; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

ANIMALS; CANNABINOID RECEPTOR MODULATORS; ENDOCANNABINOIDS; HEMOGLOBINS; HUMANS; LIGANDS; PEPTIDE FRAGMENTS; PEPTIDES; RECEPTORS, CANNABINOID;

EID: 84874659644     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.07.028     Document Type: Conference Paper

References (22)

1. K. Bellmann-Sickert, and A.G. Beck-Sickinger Peptide drugs to target G protein-coupled receptors Trends Pharmacol Sci 31 2010 434 441
2. P.A. Blais, J. Cote, J. Morin, A. Larouche, G. Gendron, and A. Fortier Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study Peptides 26 2005 1317 1322 (Pubitemid 41021465)
3. M.G. Bomar, S.J. Samuelsson, P. Kibler, K. Kodukula, and A.K. Galande Hemopressin forms self-assembled fibrillar nanostructures under physiologically relevant conditions Biomacromolecules 13 2012 579 583
4. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu Rev Biochem 75 2006 333 366 (Pubitemid 44118036)
5. L. Covic, A.L. Gresser, J. Talavera, S. Swift, and A. Kuliopulos Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides Proc Natl Acad Sci U S A 99 2002 643 648 (Pubitemid 34106565)
6. C.S. Dale, L. Pagano Rde, V. Rioli, S. Hyslop, R. Giorgi, and E.S. Ferro Antinociceptive action of hemopressin in experimental hyperalgesia Peptides 26 2005 431 436 (Pubitemid 40126700)
7. G.T. Dodd, G. Mancini, B. Lutz, and S.M. Luckman The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice J Neurosci 30 2010 7369 7376
8. E. Gazit Self assembly of short aromatic peptides into amyloid fibrils and related nanostructures Prion 1 2007 32 35
9. I. Gomes, J.S. Grushko, U. Golebiewska, S. Hoogendoorn, A. Gupta, and A.S. Heimann Novel endogenous peptide agonists of cannabinoid receptors FASEB J 23 2009 3020 3029
10. I. Gomes, C.S. Dale, K. Casten, M.A. Geigner, F.C. Gozzo, and E.S. Ferro Hemoglobin-derived peptides as novel type of bioactive signaling molecules AAPS J 12 2010 658 669
11. A.S. Heimann, I. Gomes, C.S. Dale, R.L. Pagano, A. Gupta, and L.L. de Souza Hemopressin is an inverse agonist of CB1 cannabinoid receptors Proc Natl Acad Sci U S A 104 2007 20588 20593
12. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, and W.A. Devane International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 2002 161 202 (Pubitemid 34575709)
13. D.M. Lambert, and C.J. Fowler The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications J Med Chem 48 2005 5059 5087 (Pubitemid 41113892)
14. J. Lazary, G. Juhasz, L. Hunyady, and G. Bagdy Personalized medicine can pave the way for the safe use of CB receptor antagonists Trends Pharmacol Sci 32 2011 270 280
15. F. Marcus Preferential cleavage at aspartyl-prolyl peptide bonds in dilute acid Int J Pept Protein Res 25 1985 542 546
16. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
17. L.K. Miller, and L.A. Devi The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications Pharmacol Rev 63 2011 461 470
18. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
19. M.S. Rafii, and P.S. Aisen Recent developments in Alzheimer's disease therapeutics BMC Med 7 2009 7
20. V. Rioli, F.C. Gozzo, A.S. Heimann, A. Linardi, J.E. Krieger, and C.S. Shida Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme J Biol Chem 278 2003 8547 8555 (Pubitemid 36800608)
21. M. Scrima, S. Di Marino, M. Grimaldi, A. Mastrogiacomo, E. Novellino, and M. Bifulco Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights Biochemistry 49 2010 10449 10457
22. K.A. Witt, and T.P. Davis CNS drug delivery: opioid peptides and the blood-brain barrier AAPS J 8 2006 E76 E88